We recently published a list of Jim Cramer Discussed These 12 Stocks. In this article, we are going to take a look at where ...

Cencora COR +0.79% Get Free Report has outperformed the market over the past 10 years by 9.42% on an annualized basis ...

Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Cencora has an analyst consensus of Moderate Buy, with a price target consensus of $295.70, which is a 3.96% upside from current levels. In a report released yesterday, TD Cowen also maintained a Buy ...

We recently published a list of Jim Cramer is Bullish on These 10 Stocks. In this article, we are going to take a look at ...

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cencora (COR) to $288 from $263 and keeps an Equal Weight rating on the ...

“I always talk to you about the drug middlemen. Companies like McKesson and Cencora, these are two money machines no matter ...

Shares of Cencora Inc. COR rose 1.92% to $279.15 Thursday, on what proved to be an all-around grim trading session for the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Johnson ...

Shares of Cencora Inc. COR slid 1.38% to $274.56 Monday, on what proved to be an all-around poor trading session for the ...